NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets protein-based biosurgery and passive immunotherapy products, will announce financial results for the first quarter ended March 31, 2007 after the close of U.S. financial markets on Tuesday, May 8, 2007. An accompanying conference call to discuss the results will be held the same day at 5:00 pm ET; 2:00 p.m. PT.
